AKA
a.k.a. Brands Holding Corp.
AKA's outlook is improving, though it still trails on the overall score.
AMZN
Amazon.com, Inc.
AMZN has the edge over AKA overall, supported by stronger valuation and stronger modeled upside.
AKA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Weak |
AKA's revenue is currently stable, but its profitability, cash flow and balance sheet are under pressure.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
AKA PE Valuation
AKA has no meaningful PE right now: it lost money over the past year.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
AKA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Stable | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect AKA's losses to shrink, with revenue holding steady.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over AKA on the outlook, with more favorable revenue expectations.
AKA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.72 | -$0.26 |
| Q2 2026 | -$2.48 | +$0.03 |
| Q1 2026 | -$2.81 | -$0.42 |
| Q4 2025 | -$2.93 | -$0.47 |
| Q3 2025 | -$2.46 | +$0.46 |
| Q2 2025 | -$2.51 | +$6.48 |
| Q1 2025 | -$2.39 | +$6.86 |
| Q4 2024 | -$2.46 | +$6.78 |
AKA is still losing money, but far less than before: $2.72 per share over the past year, against $24.10 at its worst in late 2023.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over AKA on earnings quality, reporting a profit while its opponent remains loss making.
AKA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $161.3M | +9.7% |
| Q2 2026 | $160.1M | -0.3% |
| Q1 2026 | $132.5M | +3% |
| Q4 2025 | $164M | +3.1% |
| Q3 2025 | $147.1M | -1.9% |
| Q2 2025 | $160.5M | +7.8% |
| Q1 2025 | $128.7M | +10% |
| Q4 2024 | $159M | +6.8% |
AKA's revenue grew through 2024 and has held roughly level since: $161M last quarter, up 9.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -2.6% | -1.6 points |
| Q2 2026 | 0.7% | +1 points |
| Q1 2026 | -3.1% | +1.1 points |
| Q4 2025 | -6.6% | -4.8 points |
| Q3 2025 | -1% | +0.4 points |
| Q2 2025 | -0.3% | -0.7 points |
| Q1 2025 | -4.2% | +1 points |
| Q4 2024 | -1.8% | +1.9 points |
AKA's operating margin was −2.6% last quarter, down 1.6 points from the same quarter a year ago.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over AKA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over AKA on profitability, with a higher operating margin.
AKA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$7.4M | -2444% |
| Q2 2026 | $18.2M | +146% |
| Q1 2026 | -$6.4M | -$1.1M |
| Q4 2025 | -$3M | -198% |
| Q3 2025 | $317K | +$7.4M |
| Q2 2025 | $7.4M | +388% |
| Q1 2025 | -$5.3M | +$3.1M |
| Q4 2024 | $3.1M | -79% |
AKA has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
AKA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1% | +105K shares |
| 1 year | +2.5% | +267K shares |
| 3 years | +3% | +316K shares |
| 5 years | +3% | +326K shares |
| Available history | +16% | +1.5M shares |
AKA has 11M diluted shares, up 2.5% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $1,000 |
| Q3 2025 | $1.6M |
| Q2 2025 | $110,000 |
| Q1 2025 | $257,000 |
| Q4 2024 | $243,000 |
AKA has spent almost nothing on buybacks in the past year.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over AKA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
AKA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 69.0x | High |
| Q2 2026 | 22.5x | High |
| Q1 2026 | 72.1x | High |
| Q3 2025 | 11.3x | High |
| Q2 2025 | 20.2x | High |
| Q1 2025 | 36.8x | High |
| Q3 2022 | 5.5x | High |
| Q2 2021 | 3.8x | Elevated |
AKA's net debt is more than 20 years of its operating earnings (EBITDA), up from more than 20 years a year ago.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over AKA on leverage, with a lower net debt burden relative to earnings.
AKA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.5 | Neutral |
| Stochastic | 15.3 | Oversold |
AKA's weekly RSI is 34 (neutral) and its Stochastic is 15 (oversold).
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
AKA PE vs Consumer Cyclical Sector
AKA has no meaningful PE right now: it lost money over the past year.
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
AKA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.3 | 15% below |
| 20 week MA | $10.7 | 18% below |
| 50 week MA | $10.6 | 16% below |
| 100 week MA | $11.7 | 25% below |
| 200 week MA | $12.1 | 27% below |
AKA is in a downtrend: it's below all five of its weekly moving averages, and 27% below its 200-week average.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over AKA on trend strength, trading above more of its moving averages.
AKA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $120.0 | $104.8 | -13% |
| 2022 | $104.8 | $16.0 | -85% |
| 2023 | $16.0 | $8.05 | -50% |
| 2024 | $8.05 | $19.4 | +141% |
| 2025 | $19.4 | $11.4 | -41% |
| 2026 YTD | $11.4 | $8.82 | -22% |
AKA's yearly returns have swung widely, from +141% in 2024 to −85% in 2022. It's down 22% so far in 2026.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over AKA on returns for 2026, with the stronger performance.